Research opens door to new drug therapies for Parkinson’s disease McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson’s disease. Collaborating teams led by Dr. Edward A. Fon at the Montreal Neurological Institute and Hospital -The Neuro, and Dr. Kalle Gehring in the Department of Biochemistry at the Faculty of Medicine, have discovered the three-dimensional structure of the protein Parkin.
Live 3D images of brain’s vasculature will improve patient diagnosis and treatment The diagnosis and treatment of potentially life-threatening neurological conditions such as aneurysms and strokes will be significantly improved as a result of cutting-edge technology at the Montreal Neurological Institute and Hospital - The Neuro, at McGill University and the MUHC. The new angiosuite, inaugurated today, offers significant advantages to patients and physicians including most importantly, improved safety and outcomes. Creates a 3D “
New study shows what happens in the brain to make music rewarding A new study reveals what happens in our brain when we decide to purchase a piece of music when we hear it for the first time. The study, conducted at the Montreal Neurological Institute and Hospital – The Neuro, McGill University and published in the journal Science on April 12, pinpoints the specific brain activity that makes new music rewarding and predicts the decision to purchase music.
What is Parkinson’s Disease? Parkinson’s disease is a neurological condition related to the death of specific brain cells that produce dopamine, a chemical needed for brain cells to control muscular movement. In Parkinson’s disease, dopamine-producing cells stop functioning for reasons still unknown.
Powerful treatment improves patients’ lives and provides new insight into mechanisms of the disease A new study by Multiple Sclerosis researchers at three leading Canadian centres addresses why bone marrow transplantation (BMT) has positive results in patients with particularly aggressive forms of MS. The transplantation treatment, which is performed as part of a clinical trial and carries potentially serious risks, virtually stops all new relapsing activity as observed upon clinical examination and brain MRI scans. The study reveals how th
A team of basic and clinical scientists led by the University of Montreal Hospital* Research Centre’s (CRCHUM) Dr. Nathalie Arbour has opened the door to significantly improved treatments for the symptoms of Multiple Sclerosis (MS).
March - National Epilepsy Awareness Month The Neuro has been at the forefront of epilepsy treatment and research for over half a century. The development of “The Montreal Procedure” by Dr.
Thirty-two students from six Montreal area high schools will assemble at the Montreal Neurological Institute and Hospital – The Neuro at McGill University on February 21st to be quizzed about synapses, axons and other cerebral facts in the international contest known as the Brain Bee.
Montreal researchers find that music lessons before age seven create stronger connections in the brain If you started piano lessons in grade one, or played the recorder in kindergarten, thank your parents and teachers. Those lessons you dreaded – or loved – helped develop your brain.
Guidance proteins regulate brain plasticity February 4, 2013 - Our ability to learn and form new memories is fully dependent on the brain’s ability to be plastic – that is to change and adapt according to new experiences and environments. A new study from the Montreal Neurological Institute – The Neuro, McGill University, reveals that DCC, the receptor for a crucial protein in the nervous system known as netrin, plays a key role in regulating the plasticity of nerve cell connections in the brain.
January 29, 2013 - Addiction to cigarettes, drugs and other stimulants has been linked in the past to the brain’s frontal lobes, but now there is scientific evidence that indicates where in the frontal cortex addiction takes hold and how. Addiction could be a result of abnormal communication between two areas of the frontal lobes linked to decision-making. The discovery will undoubtedly stimulate clinical work on new therapies for millions of people who suffer from addiction. The research by lead authors Dr.
January 28, 2013 - The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two FET Flagship projects.
January 28, 2013 - A revolutionary technology has the ability to detect and diagnose Alzheimer’s disease with unprecedented accuracy. The computerized technique known as SNIPE analyzes magnetic resonance imaging (MRI) scans to capture patterns of atrophy specific to the disease in brain structures, specifically the hippocampus and entorhinal cortex. Diagnosing Alzheimer’s disease (AD) is still an inexact science, relying mainly on the patient's symptoms and performance on memory tests.
November 27, 2012 - Clinician-scientists take a unique, integrated approach that is essential to advancing science and medicine. Problems encountered in the clinic inspire research and new findings from the labs are directly applied to patients’ needs. The integrated model is a hallmark of the Montreal Neurological Institute and Hospital – The Neuro, at McGill University and the MUHC and is now being replicated worldwide.
Pioneering memory researcher Brenda Milner inducted into the Canadian Science and Engineering Hall of Fame
November 21 2012 - Dr. Brenda Milner, pioneer in the field of cognitive neuroscience whose discoveries revolutionized the understanding of memory, is being inducted into the Canadian Science and Engineering Hall of Fame today. The induction ceremony takes place at the Canada Science and Technology Museum in Ottawa. Other inductees are physicist and educator Dr. Ursula Franklin and aviation pioneer J.A.D. McCurdy.